DHHS, NIH News  
NIH Office of the Director

Friday, January 31, 2003
Mary Ann Martinez

OD Press Office
(301) 496-5787

Mark L. Rohrbaugh Appointed Director of the Office of Technology Transfer

Bethesda, Maryland — Elias A. Zerhouni, M.D., Director of the National Institutes of Health (NIH) has announced the appointment of Mark L. Rohrbaugh, Ph.D., J.D., as the director of the Office of Technology Transfer (OTT) in the Office of Intramural Research, Office of the Director, NIH. In this position, Dr. Rohrbaugh will oversee the patenting and licensing of NIH inventions and contribute to intramural and extramural technology transfer policy at the NIH and in the Department of Health and Human Services (DHHS). Dr. Rohrbaugh joined the OTT in May 2001 as deputy director and has served as acting director since September 2001. He currently represents DHHS and NIH on the National Science and Technology Council (NSTC) Technology Committee.

"We are delighted that Dr. Rohrbaugh will be taking the helm of OTT at this critical time for technology transfer, as more and more of our basic science discoveries are translated into effective preventions, diagnostics, and treatments for human disease," said Dr. Zerhouni.

In accepting this position, Dr. Rohrbaugh will now be directing the most successful technology licensing program in the federal government in terms of commercialized products, as well as the lead office for technology transfer within DHHS. The NIH technology transfer efforts have had an increasingly important role in improving the nation's health through licensing and other collaborations that have helped bring the results of NIH and FDA laboratory research to the public. During the past 10 years, NIH executed more than 1,800 licenses to inventions made by its intramural research program resulting in more than $350 million in royalties. More importantly, these efforts have resulted in the development, by its commercial partners, of more than 20 life saving drugs, vaccines, and diagnostics and more than 100 other biomedical products.

Dr. Rohrbaugh started his career at the NIH in 1991 as the Scientific Review Administrator for the Allergy, Immunology, and Transplantation Research Committee within the National Institute of Allergy and Infectious Diseases (NIAID). In 1995 he moved from the NIAID extramural program to the Office of Technology Development, serving as director of that office from 1997 to 2001. Before joining the NIH, Dr. Rohrbaugh conducted molecular and cell biology research as a McKnight Foundation Postdoctoral Fellow at the University of Minnesota and as a Research Scientist and Senior Scientist at two biotechnology companies in Minneapolis.

The NIH Office of Technology Transfer (OTT) evaluates, protects, monitors, and manages the NIH invention portfolio to carry out the mandates of the Federal Technology Transfer Act of 1986. The National Institutes of Health is an agency of the U.S. Department of Health and Human Services (DHHS).

   Back to NIH News NIH logo